Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Oct 13, 2026
Data as of Oct 16
- Traded
- Oct 13, 2026
- Disclosed
- Oct 14, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
UTHR since disclosure
−1.3%
after the sale
Similar stocks (XLV) since disclosure
+1.6%
XLV — its sector index fund
Change in closing price from Oct 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$347Kdisclosed Oct 14 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$88.1Kdisclosed Oct 14 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$812Kdisclosed Oct 14 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.3Mdisclosed Oct 14 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$276Kdisclosed Oct 14 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$44.1Kdisclosed Oct 14 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$793Kdisclosed Oct 14 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$383Kdisclosed Oct 14 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$822Kdisclosed Oct 14 · filed 1 day after the trade